Brief: Medifron DBT appoints Kim Young Ho as CEO
20/12/2016 09:23
Dec 20 (Reuters) - Medifron DBT Co Ltd 065650.KQ :
* Says Muk Hyun Sang resigned from co-CEO
* Says company's the other co-CEO, Kim Young Ho, will begin
to serve as CEO
Source text in Korean: https://goo.gl/mrnkpf
Further company coverage: 065650.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; Reuters Messaging:
Yinglan.Ma@thomsonreuters.com@reuters.net))
Recent news on Hyper
See all newsBrief: Hyper Corporation Inc To Acquire 8 Billion Won Worth Of Shares And 100% Stake In Giftletter Corp
Brief: Medifron Dbt Co Ltd To Acquire 5.9 Billion Won Worth Of Shares In Emotion Global
Brief: Medifron Dbt Co Ltd To Acquire 7.9 Billion Won Worth Of Shares In Makeus Co Ltd
Brief: Medifron DBT raises 11.03 bln won in rights issue
Brief: Medifron DBT appoints Kim Young Ho as CEO